The structural profiles are close, with Quest Diagnostics carrying a narrow edge on growth. Abbott Laboratories still has the edge on profitability, which keeps the comparison from looking entirely one-sided. The market setup broadly confirms the structural lead — Quest Diagnostics holds the more constructive position. That puts structure and market broadly in agreement — Quest Diagnostics's lead looks more confirmed than conflicted.
The comparison is based on similar long-term financial trajectories, not sector labels.
This is not just a one-metric split: both growth and stability materially support the lead.
This pair is matched through long-term financial trajectory similarity within the selected peer universe.
The pair sits on a clearly comparable long-term path, though it is not a near-twin match.
The match is driven mainly by margin consistency and capital structure.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
The largest gaps do not all point in the same direction.
Left means cheaper relative valuation. Higher means stronger structure.
The structural gap is limited here, but current pricing still leans against Abbott Laboratories.
Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.
Earnings growth is one contributing factor within the growth lead.
Profitability still favours Abbott Laboratories, with a 7.6-point operating margin advantage keeping the comparison from looking fully resolved.
The page question resolves through growth, but profitability and current pricing still keep the broader comparison from reading as fully aligned.
Break down the ABT vs DGX comparison across all dimensions with the full interactive tool.
Explore how ABT and DGX each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.